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Previous observations and clinical manifestations suggest 
the presence of ischemia in the disproportionately thick- 
ened septum of patients with hyp4rtrophic cardiomyopa- 
thy. Metabolic consequences of ischemia can be demon- 
strated with positron emission tomography. Therefore, IO 
patients with hypertrophic cardiomyopathy and an echo- 
cardiographic septum to posterior wall thickness ratio of 
1.8 f 0.4 cm (range 1.3 to 2.5) were studied with the use of 
nitrogen (N’)-I3 ammonia, carbon (C)-II palmitate and 
fluoro (F)-18 2-deoxyglucose as tracers of myocardial blood 
flow, fatty acid metabolism and exogenous glucose utiliza- 
tion. The results of positron emission tomography in 9 
patients with hypertrophic cardiomyopathy were compared 
with those in IO normal volunteers. 
In the hypertrophic cardiomyopathy group, observed 
myocardial activity of N-13 ammonia and C-11 palmitate in 
the septum was similar to that in the lateral wall. Septum to 
lateral wall tissue activity ratios averaged 1.04 + 0.15 for 
N-13 ammonia and I.04 f 0.18 for C-11 palmitate, and 
were similar to those in the normal volunteers (0.98 f 0.07 
and 0.98 2 0.03, respectively; p = h‘s). ,Myocardial clear- 
ance half-time and residual fraction of C-11 palmitate did 
not differ significantly between the septum and lateral wall. 
However, F-18 2-deoxyglucose uptake was significantly 
lower in the septum than in the lateral wall (15,768 f 4,314 
versus 19,818 2 5,234 counts/pixel: p < 0.003). The mean 
septum to lateral wall activity ratio of 0.83 f 0.21 was less 
than that observed in normal volunteers (0.92 f 0.07: p = 
NS). 
Because observed myocardial tracer activity is depen- 
dent on wall thickness (partial volume effect) and because 
the septum was thicker than the lateral wall in the patients 
with hypertrophic cardiomyopathy, observed myocardial 
tracer activities were corrected for partial volume effect. 
This correction indicated reduced blood flow and free fatty 
acid uptake in the septum, whereas the C-11 palmitate 
kinetics suggested that septal fatty acid metabolism was 
normal. The latter observation together with reduced 
rather than enhanced exogenous glucose utilization argue 
against the possibility that these mildly symptomatic pa- 
tients with hypertrophic cardiomyopathy have myocardial 
ischemia at rest, but suggest a still unknown metabolic 
defect in the disproportionately thick septum that warrants 
further investigation. 
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In the majority of patients with classic hypertrophic cardio- 
myopathy. the genetic marker (I.21 is believed to initiate a 
chain of events that begins with characteristic morphologic 
abnormalities in the disproportionately thick septum and 
results in subsequent physiologic derangements. Several 
ctiologic hypotheses have been proposed (3-7): two cur- 
rently prevail-the catecholamine and calcium hypotheses. 
which may prove to be interrelated. Angina pectoris. which 
frequently occurs in patients with hypertrophic cardiomyop- 
athy. has been assumed to reflect an imbalance of supply and 
demand resulting from increased left ventricular mass cou- 
pled with small vessel disease in the thickened ventricular 
septum ((1-l I). In addition. some patients with hypertrophic 
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cardiomyopathy produce lactate during pacing or develop 
exercise-induced thallium defects, or both (11-17). These 
clinical observations suggest the presence of ischemia in the 
hypertrophied septum during stress. We postulated that 
ischemia could be demonstrated with tracers of blood flow 
and metabolism and positron emission tomography (PET). 
To test our hypothesis, we examined 10 patients with 
hypertrophic cardiomyopathy. 
Methods 
Study patients. Ten patients (seven men and three wom- 
en) were studied; their age ranged from 19 to 63 years (mean 
47.8). All patients met clinical, echocardiographic and angio- 
graphic criteria for hypertrophic cardiomyopathy with asym- 
metric septal hypertrophy (as described later), but the origin 
of their condition varied. Three p&ients had inheritance 
patterns in parents, siblings or offspring. Of the remaining 
seven patients, three had a remote history of hyperthyroid- 
ism but were euthyroid at the time of study (one also had 
mild hypercalcemia) (4,18), and one had a history of moder- 
ate systemic hypertension but was normotensive at the time 
of the study (19). One patient did not take medication; the 
other nine were receiving either verapamil or a beta- 
adrenergic blocking agent. One patient had normal findings 
on a planar thallium-201 exercise test. Of the five patients 
who underwent cardiac catheterization, four had a left 
ventricular to aortic pressure gradient at rest and one had a 
provokable gradient. The mean ejection fraction in 4 of the 
10 patients was 0.80 i 0.07. One patient had a 60% diameter 
stenosis of the left anterior descending coronary artery. The 
patients were only mildly symptomatic: the majority had 
good exercise tolerance and reported only occasional short- 
ness of breath or chest discomfort. 
Study protocol. Each patient was informed about the 
investigative nature of the study and its potential risks and 
benefits before written consent was obtained. The study 
protocol and consent form had been approved by the Uni- 
versity of California, Los Angeles Human Subject Protec- 
tion Committee. Patients were requested to fast overnight 
and to discontinue cardiac medication for at least 24 h. 
Seven patients stated they had fasted. Six patients discon- 
tinued their medication, but three patients stated they had 
taken a beta-blocker and one had taken verapamil within 5 h 
of the study. Immediately before the positron emission 
tomographic study, heart rate, blood pressure and a 12 lead 
electrocardiogram (ECG) were recorded and two-dimen- 
sional and M-mode echocardiograms obtained. 
The patients were then placed into the whole body 
positron emission tomograph (ECAT II, CTI, Knoxville, 
Tennessee). The rectilinear transmission scan, resembling a 
low spatial resolution chest X-ray film, served for adequate 
positioning of the cross-sectional image planes through the 
heart. The location of the image planes was delineated on the 
patient’s chest with a felt pen along the lines of the low 
power neon laser beam coinciding with the tomographic 
imaging plane. Five to six contiguous cross-sectional trans- 
mission images were then recorded at 1 ,O to 1.5 cm intervals 
from the base to the apex of the heart and used for correction 
of the emission images for photon attenuation. 
Emission images of regional myocardial tracer uptake 
and clearance were acquired at the levels of the transmission 
images. Regional myocardial blood flow was evaluated with 
intravenously administered nitrogen (N)-13 ammonia (15 to 
20 mCi). Acquisition of the five to six contiguous cross- 
sectional emission images commenced 3 min after injection 
of the N-13 ammonia. Myocardial fatty acid metabolism was 
evaluated with carbon (C)-l 1 palmitate (15 to 20 mCi), which 
was administered intravenously while acquisition of serial 
images at a single mid-left ventricular level (selected from 
the N-13 ammonia images) for 60 min began. Regional 
myocardial utilization of exogenous glucose was evaluated 
with intravenous fluoro (F)-18 2-deoxyglucose (10 mCi). 
Forty minutes after tracer injection, five to six contiguous 
cross-sectional images were recorded for 10 to 12 min each. 
N-13 ammonia was administered first, followed 50 min 
later by intravenous injection and imaging of C-l 1 palmitate 
(in only seven patients), and then by F-18 2-deoxyglucose. 
N-13 ammonia, C-11 palmitate and F-18 2-deoxyglucose 
were produced as described previously (20-22). 
The medium spatial resolution mode (18 mm at full width 
half maximum of a line source) of the tomograph was used. 
The N-13 ammonia images were acquired in the decay- 
compensated mode; the time per image increased as N-13 
decayed so that comparable counts (approximately 1 million) 
were collected for each image. The serial C-11 palmitate 
images were acquired for successively longer times (for 
example, 90, 180 and 300 s) so that at least 400,000 counts 
were collected per image (maximal counts were as high as 
2.4 million). The F-18 2-deoxyglucose images were acquired 
for 10 to 12 min. All images were corrected for isotope decay 
(Fig. 1 and 2). The whole body radiation dose from a study 
including N-13 ammonia, C-11 palmitate and F-18 2- 
deoxyglucose was calculated to be 0.32 rad. 
Analysis of positron emission tomography (PET) images. 
Only cross-sectional images through the mid-left ventricle 
that included the hypertrophied septum were analyzed. 
Myocardial uptake of N-13 ammonia and F-18 2-deoxyglu- 
case and myocardial uptake and clearance of C-l 1 palmitate 
were analyzed by assigning six circular regions of interest 
(10 mm diameter) to each PET image of the left ventricular 
myocardium, three each in the septum and the lateral wall as 
described previously (23). Average myocardial tracer activ- 
ity in the septum and lateral wall was determined by aver- 
aging counts for each of the two sets of the three regions of 
interest. 
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Regional myocardial uptake of C-l I palmitate was deter- 
mined at 6 to 8 min after tracer injection when tissue C-l 1 
concentrations are highest (23). From the tissue clearance 
curve of C-l 1 palmitate, two variables were derived: 1) the 
half-time of the early rapid clearance phase (t l/2), which 
reflects the rate of fatty acid oxidation; and 2) the fraction of 
maximal myocardial C-l 1 activity that remained in tissue at 
the end of the early rapid phase. Hereafter, this value is 
referred to as the residual fraction and reflects the amount of 
fatty acid that is not immediately oxidized. Both values 
increase with &hernia. 
The cross-sectional images of N-13 ammonia and F-18 
2-deoxyglucose uptake were also submitted to a circumfer- 
ential profile analysis (24) to detect areas of increased F-18 
2-deoxyglucose uptake relative to N-13 ammonia uptake. 
which is the pattern of PET ischemia. 
Control group. In 10 normal subjects, the uptake of N-13 
ammonia. C-l 1 palmitate and F-18 deoxyglucose was ana- 
lyzed as already described on a mid-ventricular PET image. 
The values obtained in these volunteers served as a control 
and were compared with values obtained in the patients with 
hypertrophic cardiomyopathy. 
Echocardiography. The echocardiograms obtained on the 
day of the PET study were interpreted by one of us (J.K.) 
without knowledge of other patient data. The thickness of 
the septum and posterior wall and the degree of systolic 
anterior motion of the anterior mitral leaflet were measured 
by M-mode echocardiography. The extent of septal hyper- 
trophy, the presence or absence of anterolateral hypertrophy 
and the presence of systolic thickening were determined 
visually from two-dimensional long- and short-axis and 
apical two and four chamber view echocardiograms. The 
extent of hypertrophy was graded on a 10 point scale as 
described by Wigle et al. (25), as was the degree of systolic 
anterior motion of the anterior mitral leaflet (Appendix 1). 
The echocardiographic hypertrophy score was equal to 1 
in two patients (the rest peak left ventricular outflow tract 
gradient was 116 and 195 mm Hg, respectively), between 3 
Figure 1. N- 13 ammonia (NH,) (left). F-18 2-deoxyglucose (FDG) 
(middle) and C-l I palmitate (CPA) (right) images acquired at rest. 
The more basal myocardial level (Ll) is at the top, and the more 
apical level (L2) at the bottom. N-13 ammonia uptake appears 
similar in the septum (S) and lateral (L) wall, and septal F-18 
2-deoxyglucose appears less than lateral wall uptake. The early and 
late C-l 1 palmitate images represent tracer uptake and metabolism. 
respectively. C-l 1 palmitate activity appears similar in the septum 
and lateral wall for both images. Indexes of C-l I palmitate metab- 
olism, the half-time of the early rapid phase and the residual 
fraction, were similar in the septum and lateral wall (22.2 min and 
56.8%. respectively, in the septum and 23.2 min and 62.6% in the 
lateral wall), indicating similar fatty acid metabolism at these sites. 
A = anterior: P = posterior. 
and 6 in four patients and ~7 in four patients. The septal to 
posterior wall thickness ratio averaged 1.8 2 0.4 cm (range 
1.3 to 2.5. normal ~1.3). The septum thickened normally 
during systole in all 10 patients. Systolic anterior motion of 
the anterior mitral leaflet was mild in one patient, moderate 
in three and severe in six. 
Electrocardiography. Electrocardiograms obtained on 
the day of the PET study were scored for the presence of left 
ventricular hypertrophy with use of standard criteria (Ap- 
pendix 2) (26) and evaluated for abnormal Q waves and the 
R/S ratio in lead V, (27,28). 
Two patients had no ECG evidence of left ventricular 
hypertrophy. one patient had possible left ventricular hyper- 
trophy and the remaining seven patients met the criteria for 
left ventricular hypertrophy. Six patients had deep Q waves 
in leads V, to V,. In two patients (brothers), the R/S ratio in 
lead V, exceeded 0.2. The patient with a 607~ left anterior 
descending coronary artery stenosis had first degree atrio- 
ventricular block and right bundle branch block. 
Statistical analysis. Mean values are given with standard 
deviations. All data were analyzed with Student’s t test for 
paired or unpaired data. Probability (p) values of co.05 were 
considered statistically significant. 
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NH3 FDG 
Figure 2. N-13 ammonia (NH,) (left) and F-18 2-deoxyglucose 
(FDG) (right) images acquired at rest. Three contiguous myocardial 
levels are shown from the base of the heart (Ll) (top) toward the 
apex (L3) (bottom). The septum (S) is at the upper right, the anterior 
wall (A) is at the upper left, the lateral wall (L) is at the lower left and 
the posterior (P) mitral valve is at the lower right. N-13 ammonia 
uptake in the septum appears similar to uptake in the lateral wall 
(N-13 ammonia septal and lateral wall counts were 20,560 and 
19,836, respectively). Septal uptake of F-18 2-deoxyglucose (within 
dotted lines) is severely reduced compared with uptake in the lateral 
wall. This reduction can be detected visually. F-18 2-deoxyglucose 
septal and lateral wall counts were 10,464 and 25,791, respectively. 
Thus, septal F-18 2-deoxyglucose uptake is decreased compared 
with N-13 ammonia uptake in this study acquired at rest. This 
pattern is the opposite of the pattern indicative of ischemia. 
Results 
Clinical, hemodynamic and laboratory characteristics in 
nine patients. Three patients experienced a transient epi- 
sode of chest discomfort on the day of study, two at the 
beginning of the day and one during acquisition of the F-18 
2-deoxyglucose images. Rest heart rate averaged 68 -t 13 
beatslmin, systolic blood pressure 127 2 8 mm Hg and 
diastolic blood pressure 81 t 10 mm Hg. The heart rate- 
systolic blood pressure product was 8,649 2 1,926. 
The five patients who underwent cardiac catheterization 
had a greater incidence of severe systolic anterior motion of 
the mitral valve than did the five who did not (four versus 
two). The latter group had a higher echocardiographic score 
(4.8 ? 3.6 versus 5.6 2 2.8, p = NS). 
Venous insulin levels obtained in six patients were in the 
fasting range (~24 @/ml) in five. In the fasted patients 
whose blood samples were obtained at the beginning and end 
of the metabolic studies, venous plasma concentrations of 
glucose and neutral fatty acid remained constant throughout 
the study period (glucose 92.0 + 5.7 versus 87.8 ? 3.6 mgldl, 
p = NS; neutral fatty acids 0.26 + 0.12 versus 0.33 t 0.06 
mmollliter, p = NS). 
Regional myocardial uptake of N-13 ammonia, C-11 pal- 
mitate and F-18 2.deoxyglucose. Position emission tomo- 
graphic images revealed ischemia in only one patient, but it 
did not involve the entire interventricular septum and was 
confined to its anterior part and the anterior wall. In this 
patient, nitrogen-l 3 ammonia concentration was reduced in 
these regions, whereas that of F-18 2-deoxyglucose was 
increased. The patient did not have chest pain on the study 
day, and this finding was ascribed to the presence of the 60% 
diameter stenosis of the left anterior coronary artery. This 
patient was, therefore, excluded from further analysis. 
In the other nine patients, observed myocardial N-13 
tissue activity was similar in the septum and lateral wall 
(19,231 2 4,170 and 18,532 t 3,574 counts/pixel, respec- 
tively, p = NS) (Fig. I). The septum to lateral wall activity 
ratio averaged 1.04 1- 0.15 and, thus, was similar to the ratio 
of 0.98 + 0.07 in the 10 volunteers. 
In the six of the seven patients studied with C-11 palmi- 
t&e who did not have PET evidence of ischemia, observed 
myocardial C-I I uptake in the septum and lateral wall was 
similar (17,912 2 2,566 and 17,708 ? 4,348 counts/pixel, 
respectively, p = NS). The average septal to lateral wall 
activity ratio of 1.04 t- 0.18 in these six patients was not 
significantly different from the ratio of 0.98 + 0.03 (p = NS) 
in the seven normal volunteers (Fig. 3A). Furthermore, 
clearance half-time of the early rapid phase and the residual 
fraction was similar in the septum and the lateral wall (early 
rapid phase 21.0 2 4.7 versus 20.2 t 4.2 min, respectively; 
residual fraction 57.3 ? 3.0 versus 58.5 ‘_ 5.2%, respec- 
tively). However, in the patient with a 60% diameter left 
anterior descending coronary artery stenosis, the half-time 
of the early rapid phase was longer in the septum (33.8 min) 
than in the lateral wall (22.5 min), a finding consistent with 
impaired fatty acid oxidation. 
However, the findings with F-18 2-deoxyglucose differed 
significantly from those with N-13 ammonia and C-l I palmi- 
tate (Fig. 1, 2 and 3A). The observed myocardial F-18 
2-deoxyglucose tissue concentration was lower in the sep- 
tum than in the lateral wall in the seven patients with 
adequate images (15,768 + 4,314 versus 19,818 -t 5,234 
counts/pixel, respectively, p = NS). Adequate F-18 2- 
deoxyglucose images were not obtained in all 10 patients 
because preferential myocardial fatty acid utilization in the 
fasted state suppressed myocardial uptake of glucose and, 
thus, of F-18 2-deoxyglucose. The septum to lateral wall 
F-18 2-deoxyglucose activity ratio averaged 0.83 ? 0.21, a 
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Figure 3. A, Septum to lateral wall activity ratios for observed 
counts in IO normal volunteers (open bars) and 9 patients with 
hypertrophic cardiomyopathy (HCM) (hatched bars) for N-13 am- 
monia, C-l I palmitate and F-18 2-deoxyglucose. The observed 
activity ratios are similar for all three tracers, although the ratio for 
F-18 2-deoxyglucose in the patients is lower than that in the normal 
volunteers. whereas the ratios for the two other tracers are slightly 
higher in the patients than in the volunteers. *p < 0.05 versus NH, 
for HCM. B, Relation of wall thickness and observed counts. Wall 
thickness is on the x axis and observed counts (expressed as a 
recovery coefficient) on the y axis. In a 25 mm thick septum, the 
majority of actual counts are observed (line B). However, in an I I 
mm thick lateral wall, the actual counts are underestimated by 
approximately 50% (line A). Therefore, actual counts in the lateral 
wall are underestimated by these images. C, Septum to lateral wall 
activity ratios for counts corrected for the thickness of the septum 
and lateral wall in patients with hypertrophic cardiomyopathy as 
measured by echocardiography. The data for normal volunteers are 
shown by open bars and for patients with hypertrophic cardiomy- 
opathy by hatched bars for N-13 ammonia, C-l I palmitate and F-18 
Ldeoxyglucose. The corrected activity ratios are significantly lower 
in the patients than in the normal volunteers for all three tracers. p 
< 0.001 versus normal. 
value that tended to be lower than that in the normal 
volunteers (average ratio 0.92 ? 0.07, p = NS). Importantly, 
this ratio was significantly lower than the ratio of N-13 
ammonia (p < 0.05) and tended to be lower than the ratio for 
C-l I palmitate uptake (p = 0.08) in the patients with hyper- 
trophic cardiomyopathy. 
Patients nvho took either N hetu-blocker or verapamil 
hefore the study had a similar septal to lateral wall activity 
ratio for blood flow and exogenous glucose uptake as that of 
patients who did not take medication (blood flow ratio 0.94 + 
0.09 versus 1.04 + 0.17, p = NS; F-18 2-deoxyglucose ratio 
0.83 2 0.07 versus 0.82 t 0.36, p = NS). This argues against 
an effect of antianginal medications on metabolism. 
The septum to latertrl wall ucti\Gty ratio ftir hlood~ow in 
the three patients nvith chest puin on the da_v of the study was 
similar to the ratio in patients without chest pain (I .04 + 0.14 
versus 1.05 ? 0.15, p = NS). Myocardial F-18 2-deoxy- 
glucose uptake was adequate for analysis in only one of the 
three patients who had chest pain on the day the F-18 
2-deoxyglucose images were acquired. In this patient, the 
septal to lateral wall activity ratio was 0.81. 
Discussion 
In this group of nine mildly symptomatic patients with 
hypertrophic cardiomyopathy and without significant coro- 
nary artery disease, positron emission tomography (PET) 
revealed homogeneous uptake of N-13 ammonia and C-l I 
palmitate. The observed homogeneous distribution of trac- 
ers did not differ significantly from that in normal volunteers. 
Furthermore, after the administration of intravenous C-l I 
palmitate, both the lateral wall and interventricular septum 
revealed similar tissue C-l I clearance kinetics on serial PET 
imaging. Importantly, however. the disproportionately 
thickened septum accumulated significantly less F-18 2- 
deoxyglucose relative to the lateral wall. 
Myocardial blood flow in the thickened septum. Exercise 
studies using thallium-201 as a tracer of blood flow have 
demonstrated variable septal perfusion patterns including no 
defect, fixed defect and reversible defect (14-17). One report 
(29) described reduced blood flow to the interventricular 
septum even at rest, whereas another report did not (30). 
Homogeneous distribution of N-13 ammonia in the nine 
patients in this study without significant coronary artery 
disease suggests that blood flow to the interventricular 
septum was normal. The average septum to lateral wall 
activity ratio calculated in these patients with semiquantita- 
tive analysis approached unity (I .04 -C 0. IS), a value similar 
to that obtained in the normal volunteers. again supporting 
an apparent normalcy of septal blood flow at rest in these 
patients. 
However, tissue activity concentrations as reflected by 
and directly determined from the cross-sectional images do 
not necessarily represent true tracer tissue concentrations. 
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The partial volume effect, common to all imaging tech- 
niques, causes an underestimation of true tissue tracer 
concentration when the size of the imaged object (in our 
study, the thickness of the myocardial wall) is less than twice 
the spatial resolution of the imaging device (3 1). The marked 
regional differences in myocardial wall thickness present in 
our patients with hypertrophic cardiomyopathy and a dis- 
proportionately thickened septum would, therefore, lead to a 
markedly heterogeneous distribution of observed tracer con- 
centrations on the cross-sectional images (Fig. 3B). How- 
ever, the images demonstrate a rather homogeneous distri- 
bution of tracers throughout the left ventricular myocardium 
and septum. This suggests the presence of regional differ- 
ences in true tracer concentration. True tissue concentration 
can be calculated from the images by correcting the under- 
estimation of tracer tissue concentration from measured wall 
thickness and the known relation between wall thickness and 
the degree of underestimation. Inhomogeneous septal hyper- 
trophy makes precise determination of wall thickness in the 
image plane difficult. However, if one assumes that the 
echocardiographically measured thickness of the posterior 
wall equaled that of the posterolateral wall on PET imaging, 
an assumption that nuclear magnetic resonance images con- 
firmed as correct in three patients, correction of the regional 
tissue concentration for the regional partial volume effect 
with use of echocardiographic measurements altered the 
septum to lateral wall activity ratio (Fig. 3C). The ratio for 
N-l 3 ammonia declined to 0.68 ? 0.09, indicating an average 
32% reduction in blood flow in the interventricular septum 
relative to the lateral wall. 
Thus, consistent with previous reports, all nine patients 
analyzed in this manner revealed a relative decrease in blood 
flow in the disproportionately thick septum. Abnormal intra- 
mural septal coronary arteries (8,9) provide an anatomic 
explanation, and septal perforator artery compression and 
impaired diastolic relaxation (24,32) provide physiologic 
explanations of why myocardial blood flow in the septum 
might be reduced relative to blood flow in the lateral wall. 
Fatty acid metabolism and glucose utilization. Myocardial 
uptake of C-11 palmitate also appeared to be homogeneous 
on the PET images in patients with hypertrophic cardiomy- 
opathy. This observation was confirmed by the average 
septum to lateral wall activity ratio of 1.04 t 0.18, which 
approached unity and was similar to the average ratio in the 
seven normal volunteers. However, as mentioned for blood 
flow, the partial volume effect caused a relative overestima- 
tion of true myocardial tissue concentration of C-l 1 palmi- 
tate uptake. After correction for partial volume effect, the 
septum to lateral wall activity ratio declined to 0.71 ? 0.08. 
Thus, relative to the lateral wall, C-l 1 palmitate uptake was 
decreased by 29% in the septum and, therefore, paralleled 
the reduction in blood flow. Rather than reflecting an abnor- 
mality of fatty acid metabolism, the reduced C-l 1 palmitate 
uptake in the interventricular septum was most likely a 
function of decreased blood flow, as previously demon- 
strated in animal experiments (33). 
Regional differences in wall stress and metabolism be- 
tween the septum and lateral wall may provide an alternate 
explanation for regional differences in blood flow and C-l 1 
palmitate uptake. However, nearly identical C-l 1 palmitate 
clearance rates in the septum and lateral wall together with a 
disproportionately greater difference in exogenous glucose 
utilization render such explanation less likely. 
Role ofischemia. Although the reduction in blood flow 
and C-l 1 palmitate uptake in the thickened septum would be 
consistent with our hypothesis of ischemia, the tissue clear- 
ance kinetics of C-l 1 palmitate argue against ischemia. First, 
no significant difference existed in clearance half-times of the 
early rapid clearance phase and in residual fractions between 
the septum and the lateral wall in patients with hypertrophic 
cardiomyopathy. Second, the average clearance half-time of 
21.0 2 4.7 min and residual fraction of 57.3 ? 3.0% in the 
septum of patients with hypertrophic cardiomyopathy were 
virtually identical with those previously reported (22) in 
normal human myocardium (clearance half-time 22.2 + 5.2 
min and residual fraction 54.0 ? 6.1%). The significantly 
lower septum to lateral wall ratio for F-18 2-deoxyglucose 
compared with that for N-13 ammonia argues further against 
the presence of ischemia at rest in the interventricular 
septum. This comparison is made for the same regions in a 
given patient; therefore, the partial volume effect is the same 
for both N-13 ammonia and F-18 2-deoxyglucose. Because 
the partial volume effect cancels out for this comparison, this 
value is not dependent on a correction factor. The relative 
reduction in F-18 2-deoxyglucose uptake averaged 45%, as 
reflected by the average septum to lateral wall activity ratio 
of 0.55 ? 0.14 after regional tracer tissue concentrations 
were corrected for partial volume effect. 
Taking medication did nor appear to uffect the results. 
Similar to results for the observed septal to lateral wall 
activity ratio, the corrected septal to lateral wall activity 
ratios for blood flow and exogenous glucose uptake were 
similar in patients who took either a beta-blocker or verapa- 
mil before the study and those who did not take medication. 
Comparison with previous reports. If the primary meta- 
bolic abnormality in the thickened interventricular septum at 
rest had been ischemia, we would have expected to observe 
on the PET study the regional delay in C-l 1 palmitate tissue 
clearance as well as a relative or absolute increase in F-18 
2-deoxyglucose uptake. Such ischemia-related abnormalities 
had previously been observed in animal experimental studies 
and in patients with ischemic heart disease (34-36). Our PET 
findings are at variance with several reports (1 l-13) of 
decreased extraction or even release of lactate in patients 
with hypertrophic cardiomyopathy as a sign of ischemia, 
although the majority of these abnormalities in lactate me- 
tabolism were observed only during atria1 pacing or exercise. 
In view of the previously reported vascular abnormalities 
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and limited coronary flow reserve in patients with hypertro- 
phic cardiomyopathy, it is possible that exercise or atria1 
pacing would have induced a metabolic pattern on PET 
images that would be consistent with ischemia. However, in 
this group of mildly symptomatic patients with hypertrophic 
cardiomyopathy, PET studies at rest did not demonstrate 
metabolic alterations consistent with ischemia, except in the 
anterior septum and anterior wall in a patient without recent 
chest pain on the study day but with moderate stenosis in the 
mid-left anterior descending coronary artery. PET evidence 
of ischemia has been observed previously (23,35) in patients 
without recent chest pain who have coronary artery disease. 
It is of note that glucose uptake in the proximal septum in 
this patient was decreased, as observed in the other patients 
with hypertrophic cardiomyopathy. Even the patient who 
experienced chest pain during the PET study did not have 
evidence of ischemia, suggesting that the pain was either of 
nonischemic origin or that &hernia was insufficient to evoke 
sufficiently large metabolic abnormalities that would over- 
ride the observed metabolic pattern at rest. Whether these 
findings will be present in more symptomatic patients re- 
quires further investigation. 
Initial observations in four patients studied with F-18 
2-deoxyglucose and two studied with N-13 ammonia at 
maximal exercise demonstrated similar results with a slightly 
lower septal to lateral wall ratio of F- 18 2-deoxyglucose than 
at rest. Thus, metabolic evidence for myocardial ischemia 
during exercise was not observed in these patients. 
Role of increased regional catecholamine stimulation in the 
thickened septum. A possible explanation for the relative 
decrease in septal glucose utilization and, thus, for a primary 
metabolic abnormality in the septum, is inhibition at the 
level of glucose uptake. Merhige et al. (37) demonstrated 
that catecholamine infusion suppressed myocardial glucose 
metabolism in normal canine myocardium, probably because 
of the increased availability of fatty acids. Norepinephrine 
produces myocyte growth in tissue cultures (381, and long- 
term norepinephrine infusion alters canine ventricular septal 
beta-adrenergic receptors and cyclic adenosine monophos- 
phate (AMP) (3). It has been argued (6) that, in inherited 
hypertrophic cardiomyopathy, a genetically determined bio- 
chemical abnormality of the ventricular septum may result in 
deranged interaction in utero between sympathetic nerve 
endings and receptor sites (catecholamine hypothesis). Con- 
sistent with the observations of Merhige et al. (37), increased 
regional catecholamine stimulation may result in the sup- 
pression of septal myocardial glucose uptake and provide an 
explanation for our findings if levels of catecholamines or 
their receptors were elevated regionally in the disproportion- 
ately thick septum in patients with classic hypertrophic 
cardiomyopathy. The increased septal glycogen content 
observed in hypertrophic cardiomyopathy (39-41) may re- 
flect the suppression of myocardial glucose utilization. 
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Appendix 1: Echocardiographic Score 
for Hypertrophy 
The echocardiographic score depended on septal thick- 
ness in the basal one-third of the septum (5 19 mm = I point. 
20 to 24 mm = 2 points, 25 to 29 mm = 3 points, 230 mm = 
4 points) and on extension of hypertrophy to the papillary 
muscles (2 points), the apex (2 points) and the anterolateral 
wall (2 points). 
The degree of systolic anterior motion of the anterior 
mitral leaflet was defined as mild if the leaflet was >I0 mm 
from the septum. moderate if the leaflet was within 10 mm of 
the septum or if septal-leaflet contact lasted for <30% of 
echocardiographic systole and severe if septal-leaflet contact 
lasted >30% of echocardiographic systole. 
Appendix 2: Electrocardiographic Criteria 
for Left Ventricular Hypertrophy 
Three points were given for the presence of an abnormal 
P wave in lead V,, for QRS height 220 mm in a limb lead or 
230 mm in a precordial lead or the sum of the R and S waves 
245 mm and for the ST-T segment opposite in direction from 
the QRS complex (in the absence of digitalis therapy). Two 
points were given for the presence of a frontal plane axis 
z-30”. and 1 point was given for QRS duration in a limb 
lead 20.09 s or for deflection 20.05 s. Electrocardiographic 
left ventricular hypertrophy was defined as definite with 6 
points, probable with 5 points and possible with 4 points. 
I. 
2. 
3. 
4. 
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